These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18204915)

  • 1. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.
    Kwon DH; Setser RM; Popović ZB; Thamilarasan M; Sola S; Schoenhagen P; Garcia MJ; Flamm SD; Lever HM; Desai MY
    Int J Cardiovasc Imaging; 2008 Aug; 24(6):617-25. PubMed ID: 18204915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
    Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
    Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
    J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.
    Kwon DH; Smedira NG; Rodriguez ER; Tan C; Setser R; Thamilarasan M; Lytle BW; Lever HM; Desai MY
    J Am Coll Cardiol; 2009 Jul; 54(3):242-9. PubMed ID: 19589437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
    Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased extent of myocardial fibrosis in genotyped hypertrophic cardiomyopathy with ventricular tachyarrhythmias.
    Fujita T; Konno T; Yokawa J; Masuta E; Nagata Y; Fujino N; Funada A; Hodatsu A; Kawashiri MA; Yamagishi M; Hayashi K
    J Cardiol; 2015 Jul; 66(1):63-8. PubMed ID: 25458192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.
    Suk T; Edwards C; Hart H; Christiansen JP
    Heart Lung Circ; 2008 Oct; 17(5):370-4. PubMed ID: 18562248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis.
    Debl K; Djavidani B; Buchner S; Lipke C; Nitz W; Feuerbach S; Riegger G; Luchner A
    Heart; 2006 Oct; 92(10):1447-51. PubMed ID: 16606864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.
    Kwon DH; Desai MY
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):85-7. PubMed ID: 17541762
    [No Abstract]   [Full Text] [Related]  

  • 14. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
    Fluechter S; Kuschyk J; Wolpert C; Doesch C; Veltmann C; Haghi D; Schoenberg SO; Sueselbeck T; Germans T; Streitner F; Borggrefe M; Papavassiliu T
    J Cardiovasc Magn Reson; 2010 May; 12(1):30. PubMed ID: 20492668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
    Hen Y; Iguchi N; Machida H; Takada K; Utanohara Y; Sumiyoshi T
    Heart Vessels; 2013 Nov; 28(6):742-9. PubMed ID: 23097076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E; Maron BJ; Adabag S; Hauser TH; Lesser JR; Haas TS; Riley AB; Harrigan CJ; Delling FN; Udelson JE; Gibson CM; Manning WJ; Maron MS
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):78-85. PubMed ID: 22135401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
    Kwon DH; Halley CM; Carrigan TP; Zysek V; Popovic ZB; Setser R; Schoenhagen P; Starling RC; Flamm SD; Desai MY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):34-44. PubMed ID: 19356530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.